Proposed class action lawsuit filed against Canadian maker of popular weight loss drug Ozempic

A proposed class action lawsuit has been filed in the British Columbia Supreme Court, alleging that the Canadian manufacturer of Ozempic failed to warn potential patients of possible complications.

This medication has exploded in popularity since doctors began prescribing it for weight loss.

But Tracy Nygaard, 54, was taking Ozempic for its intended purpose, treating type 2 diabetes. After her first dose, she knew something was wrong.

My stomach hurt so much, I had pain, bloating and vomiting, Nygaard said from her home in Quesnel.

Ozempic was very effective at controlling his blood sugar, so Nygaard’s doctor suggested he keep up with the injections once a week. But the side effects persisted.

One of the reactions I got was that I went to the emergency room. I said I couldn’t handle this anymore, said Nygaard, who eventually stopped talking about Ozempic.

I’m afraid I’ll have permanent damage now, Nygaard said. I wish I had been warned that there were serious side effects before I started taking it, so that I could have made an informed decision.

She joined the proposed class action for Canadians who claim they suffered serious complications while taking Ozempic for diabetes or weight loss, and believe they were not informed of this risk.

It was filed by Siskinds, an Ontario law firm specializing in medical class actions, and focuses on the drug makers’ alleged failure to warn potential patients of possible serious side effects.

We have already heard from dozens of Canadians who have contacted us and said that they thought they fit the class definition, that they had taken Ozempic or one of these other drugs and then suffered from certain of these serious gastrointestinal or gallbladder problems. problems, said Siskinds associate attorney James Boyd.

He added that some of the people who contacted his company were suffering from what is called stomach paralysis.

This is a condition in which food remains in the digestive system and is slow to be cleared, causing severe stomach pain to the point where some people feel as if their stomach is in a state of collapse. paralysis, Boyd said.

Nygaard thinks this is what happened to her when she took Ozempic. For some people like me, you experience an adverse reaction to this delayed digestion, she said.

Dr. Yashar Tashakkor, a North Vancouver doctor who specializes in obesity, says Ozempic is designed to slow down the digestive tract, adding that’s why it helps people lose weight.

In general, I cite that my patients, about 10 percent of them, may experience nausea as well as vomiting, he said.

Dr. Tashakkor did not see any stomach paralysis in any of his patients, who he said benefited greatly from taking Ozempic. But he says he will raise the possibility now.

This will be something that I will discuss with my patients and say that there is some evidence that might suggest this. I have not encountered any cases, it is rare, but my job is to inform patients of all the risks and benefits that I am aware of, Tashakkor said.

In a statement, Novo Nordick, the Canadian manufacturer of Ozempic and other similar drugs named in the proposed class action, said: Novo Nordisk guarantees the safety and effectiveness of all of our GLP-1 drugs when used used by appropriate patients in accordance with the product. approved labeling and indications.

None of the proposed class action claims have been tested in court. Ultimately, a judge will decide whether this will be certified, and patients like Nygaard will be able to seek relief.

#Proposed #class #action #lawsuit #filed #Canadian #maker #popular #weight #loss #drug #Ozempic
Image Source : bc.ctvnews.ca

Leave a Comment